The patient's laboratory results revealed low levels of IGF-1 (15 ng/ml), normal levels of IGF-2 (395 ng/ml), and an elevated IGF-2-to-IGF-1 ratio of 26:1, indicating non-islet cell tumor hypoglycemia. This evidence concerns the gene IGF1 and pancreatic neuroendocrine tumor.